Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: Basic and clinical studies
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Brain Research Bulletin
- Vol. 40 (1) , 1-19
- https://doi.org/10.1016/0361-9230(96)00010-x
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to agingBrain Research, 1993
- Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated miceNeuropharmacology, 1992
- Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?Annals of Neurology, 1990
- Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging miceExperimental Neurology, 1990
- Adrenal to caudate transplantation—postmortem studyMovement Disorders, 1990
- Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patientsExperimental Neurology, 1989
- Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in cultureDevelopmental Biology, 1989
- Chronic intrastriatal dopamine infusions in rats with unilateral lesions of the substantia nigraLife Sciences, 1987
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986